Young people taking antidepressants likely to be more violent
Advertisement
An international study published in the PLoS Medicine Journal has indicated a further investigation to be done in young patients (between 15-24 age group) who are on anti-depressants such as Prozac and Seroxat. In the initial findings, the study suggests that young people who take less dose of anti-depressants are more likely to conduct violent crimes, than people controlled by higher dosage of these medicines.
Further studies should be conducted and extra warnings may be needed in future when they are prescribed to people aged 15 to 24, says the study as confirmed by Reuters.
Selective Serotonin Re-uptake Inhibitors (SSRIs) are a class of widely prescribed drugs, including fluoxetine, branded by Eli Lilly as Prozac, and GlaxoSmithKline's paroxetine, branded as Paxil or Seroxat, designed to ease symptoms of anxiety and depression.
Further studies should be conducted and extra warnings may be needed in future when they are prescribed to people aged 15 to 24, says the study as confirmed by Reuters.
Selective Serotonin Re-uptake Inhibitors (SSRIs) are a class of widely prescribed drugs, including fluoxetine, branded by Eli Lilly as Prozac, and GlaxoSmithKline's paroxetine, branded as Paxil or Seroxat, designed to ease symptoms of anxiety and depression.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.